2018, Número 1
<< Anterior Siguiente >>
Med Crit 2018; 32 (1)
Asociación entre el nivel de cortisol sérico y la mortalidad en pacientes postquirúrgicos con choque hipovolémico hemorrágico
Díaz GSP, Sánchez DJS, Martínez REA, García MRC, Peniche MKG, Calyeca SMV
Idioma: Español
Referencias bibliográficas: 33
Paginas: 7-12
Archivo PDF: 210.84 Kb.
RESUMEN
Introducción: El uso de corticosteroides para el tratamiento de pacientes con choque séptico ha llevado a considerar su empleo en otros procesos patológicos, entre ellos, el choque hipovolémico hemorrágico, aunque con resultados controversiales.
Material y métodos: Se realizó un estudio de cohorte, prospectivo, longitudinal, observacional y analítico. Se incluyeron pacientes ingresados a la Unidad de Cuidados Intensivos (UCI) con diagnóstico de choque hipovolémico hemorrágico secundario a evento quirúrgico en el periodo comprendido entre el 1 de enero y el 31 de julio de 2017.
Resultados: Por medio de la curva ROC se estableció el punto de corte para el cortisol sérico al ingreso a la UCI, estimado en 39.1 µg/dL, con área bajo la curva de 1.00 (IC95% 0.0012-0.2487, p = 0.0001). La sensibilidad fue de 100%, con especificidad de 100%; los coeficientes de probabilidad positivo y negativo fueron de 14 y cero, respectivamente.
Conclusión: Los niveles de cortisol sérico medidos al ingreso a la UCI superiores a 39.1 µg/dL se asocian con mayor mortalidad en los pacientes postquirúrgicos con choque hipovolémico hemorrágico.
REFERENCIAS (EN ESTE ARTÍCULO)
Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 1984;5(1):25-44.
Newton R. Molecular mechanisms of glucocorticoid action: what is important? Thorax. 2000;55(7):603-613.
Tsigos C, Chrousos GP. Hypothalamic pituitary adrenal axis, neuroendocrine factors and stress. J Psychosomatic Res. 2002;53(4):865-871.
Stein DM, Jessie EM, Crane S, Kufera JA, Timmons T, Rodriguez CJ, et al. Hyperacute adrenal insufficiency after hemorrhagic shock exists and is associated with poor outcomes. J Trauma Acute Care Surg. 2013;74(2):363-370.
Mejía-Gómez LJ. Fisiopatología choque hemorrágico. Rev Mex Anest. 2014;37(1):S70-S76.
Mutschler M, Nienaber U, Münzberg M, Fabian T, Paffrath T, Wölfl C, et al. Assessment of hypovolaemic shock at scene: is the PHTLS classification of hypovolaemic shock really valid? Emerg Med J. 2014;31(1):35-40.
Zaloga G, Marik P. Hypothalamic-pituitary-adrenal insufficiency. Crit Care Clin. 2001;17(1):25-41.
Bates AS, Van't Hoff W, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab. 1996;81(3):1169-1172.
Price SA, Spain DA, Wilson MA, Harris PD, Garrison RN. Altered vasoconstrictor and dilator responses after a “two-hit” model of sequential hemorrhage and bacteremia. J Surg Res. 1999;81(1):59-64.
Arlt W, Allolio B. Adrenal insufficiency. The Lancet. 2003;361(9372):1881-1893.
Maxime V, Lesur O, Annane D. Adrenal insufficiency in septic shock. Clin Chest Med. 2009;30(1):17-27.
Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg. 1976;184(3):333-341.
Rushing GD, Britt RC, Britt LD. Effects of hemorrhagic shock on adrenal response in a rat model. Ann Surg. 2006;243(5):652-654.
Melby JC. Drug spotlight program: systemic corticosteroid therapy. Pharmacology and endocrinologic considerations. Ann Intern Med. 1974;81(4):505-512.
Reincke M, Allolio B, Wurth G, Winkelmann W. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. J Clin Endocrinol Metab. 1993;77(1):151-156.
Sibbald WJ, Short A, Cohen MP, Wilson RF. Variations in adrenocortical responsiveness during severe bacterial infections: unrecognized adrenocortical insufficiency in severe bacterial infections. Ann Surg. 1977;186(1):29-33.
Smith SM, Vale WW. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci. 2006;8(4):383-395.
Hietbrink F, Koenderman L, Rijkers G, Leenen L. Trauma: the role of the innate immune system. World J Emerg Surg. 2006;1:15.
Rodríguez ND, Rodríguez AM, Alfonso AL, Castellanos PE, Reyes MM, Quintana RM. Respuesta metabólica en el trauma. Rev Cub Med Mil. 2012;41(1):96-104.
Guirao X, Lowry SF. Biologic control of injury and inflammation: much more than too little or too late. World J Surg. 1996;20(4):437-446.
Schelling G, Stoll C, Kapfhammer HP, Rothenhäusler HB, Krauseneck T, Durst K, et al. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder and health-related quality of life in survivors. Crit Care Med. 1999;27(12):2678-2683.
Joseph B, Haider AA, Pandit V, Kulvatunyou N, Orouji T, Khreiss M, et al. Impact of hemorrhagic shock on pituitary function. J Am Coll Surg. 2015;221(2):502-508.
Bernard F, Outtrim J, Menon DK, Matta BF. Incidence of adrenal insufficiency after severe traumatic brain injury varies according to definition used: clinical implications. Br J Anaesth. 2006;96(1):72-76.
Weant KA, Sasaki-Adams D, Dziedzic K, Ewend M. Acute relative adrenal insufficiency after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2008;63(4):645-649.
De Waele JJ, Hoste EA, Baert D, Hendrickx K, Rijckaert D, Thibo P, et al. Relative adrenal insufficiency in patients with severe acute pancreatitis. Intensive Care Med. 2007;33(10):1754-1760.
Huang CJ, Lin HC. Association between adrenal insufficiency and ventilator weaning. Am J Respir Crit Care Med. 2006;73(3):276-280.
Casares VM, Raurich PJ, Ayestarán RI, Llompart SE, Ibáñez Juvé J. Shock séptico e insuficiencia suprarrenal relativa. Med Intensiva. 2003;27(8):525-530.
Albert SG, Ariyan S, Rather A. The effect of etomidate on adrenal function in critical illness: a systematic review. Intensive Care Med. 2011;37(6):901-910.
Pene F, Hyvernat H, Mallet V, Cariou A, Carli P, Spaulding Ch, et al. Prognostic value of relative adrenal insufficiency after out-of-hospital cardiac arrest. Intensive Care Med. 2005;31(5):627-633.
Venkatesh B, Cohen J, Cooper M. Ten false beliefs about cortisol in critically ill patients. Intensive Care Med. 2015;41(10):1817-1819.
Boonen E, Vervenne H, Meersseman P, Andrew R, Mortier L, Declercq PE, et al. Reduced cortisol metabolism during critical illness. N Engl J Med. 2013;368(16):1477-1488.
Boonen E, Van den Berghe G. Cortisol metabolism in critical illness: implications for clinical care. Curr Opin Endocrinol Diabetes Obes. 2014;21(3):185-192.
Rothermel LD, Lipman JM. Estimation of blood loss is inaccurate and unreliable. Surgery. 2016;160(4):946-953.